Mechanistic insights into Hsp104 potentiation

Journal of Biological Chemistry

Volumn 291, Issue 10, 2016, Pages 5101-5115

  Torrente, Mariana P ^a,b   Chuang, Edward ^a   Noll, Megan M ^a   Jackrel, Meredith E ^a   Go, Michelle S ^a,c   Shorter, James ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; HYDROLYSIS; PROTEINS; YEAST;

AMYOTROPHIC LATERAL SCLEROSIS; ATP-ASE ACTIVITY; DNA-BINDING PROTEIN; FUSED IN SARCOMATA; NUCLEOTIDE-BINDING DOMAIN; PARKINSON DISEASE; PROTEIN AGGREGATES; SUBSTRATE BINDING;

NEURODEGENERATIVE DISEASES;

ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATASE; ALPHA SYNUCLEIN; FUSED IN SARCOMA PROTEIN; HEAT SHOCK PROTEIN 104; HEAT SHOCK PROTEIN 70; LUCIFERASE; TAR DNA BINDING PROTEIN; ADENOSINE TRIPHOSPHATE; HEAT SHOCK PROTEIN; HSP104 PROTEIN, S CEREVISIAE; PROTEIN BINDING; RECOMBINANT PROTEIN; RNA BINDING PROTEIN FUS; SACCHAROMYCES CEREVISIAE PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REACTIVATION; ENZYME SUBSTRATE COMPLEX; FUNGAL GENE; FUNGAL STRAIN; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE BINDING DOMAIN 1; NUCLEOTIDE BINDING DOMAIN 2; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; Y257A GENE; Y662A GENE; BINDING SITE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MISSENSE MUTATION; PROTEIN FOLDING; SACCHAROMYCES CEREVISIAE;

ADENOSINE TRIPHOSPHATE; ALPHA-SYNUCLEIN; BINDING SITES; HEAT-SHOCK PROTEINS; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN FOLDING; RECOMBINANT PROTEINS; RNA-BINDING PROTEIN FUS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84964632156     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.707976     Document Type: Article

References (85)

1. Höppener, J. W., Ahrén, B., and Lips, C. J. (2000) Islet amyloid and type 2 diabetes mellitus. N. Engl. J. Med. 343, 411-419
2. Kaniuk, N. A., Kiraly, M., Bates, H., Vranic, M., Volchuk, A., and Brumell, J. H. (2007) Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 56, 930-939
3. Capellari, S., Strammiello, R., Saverioni, D., Kretzschmar, H., and Parchi, P. (2011) Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol. 121, 21-37
4. Prusiner, S. B. (1998) The prion diseases. Brain Pathol. 8, 499-513
5. Forman, M. S., and Trojanowski., J. Q., and Lee, V. M. (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med. 10, 1055-1063
6. Ross, C. A., and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease. Nat. Med. 10, S10-S17
7. Lansbury, P. T., and Lashuel, H. A. (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443, 774-779
8. Spillantini, M. G., and Schmidt., M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839-840
9. Dawson, T. M., and Dawson, V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822
10. Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O'Brien, P., Trojanowski, J. Q., and Lee, V. M. (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953
11. Mahul-Mellier, A. L., Vercruysse, F., Maco, B., Ait-Bouziad, N, De Roo, M., Muller, D., and Lashuel, H. A. (2015) Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death. Cell Death Differ. 22, 2107-2122
12. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., Lansbury, P. T., Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291
13. Robberecht, W., and Philips, T. (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev. Neurosci. 14, 248-264
14. Fang, Y. S., and Tsai., K. J., Chang, Y. J., Kao, P., Woods, R., Kuo, P.H., Wu, C. C, Liao, J. Y., Chou, S.C, Lin, V., Jin, L. W., Yuan, H.S., Cheng, I.H., Tu, P.H., and Chen, Y. R. (2014) Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat Commun. 5, 4824
15. Feiler, M. S., Strobel, B., Freischmidt, A., Helferich, A. M., Kappel, J., and Brewer., B. M., Li, D., Thal, D. R., Walther, P., Ludolph, A. C, Danzer, K. M., and Weishaupt, J. H. (2015) TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 211, 897-911
16. Kao, P. F., and Chen., Y. R., Liu, X. B., DeCarli, C, and Seeley., W. W., and Jin, L. W. (2015) Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP. Ann. Neurol. 78, 211-221
17. King, O. D., and Gitler., A. D., and Shorter, J. (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 1462, 61-80
18. Li, Y. R., and King., O. D., Shorter, J., and Gitler, A. D. (2013) Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361-372
19. Neumann, M., and Sampathu., D. M., Kwong, L. K., Truax, A. C, Micsenyi, M. C, Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., and McCluskey., L. F., Miller, B. L., Masliah, E., Mackenzie, I. R., Feldman, H., Feiden, W., Kretzschmar, H. A., Trojanowski, J. Q., and Lee, V. M. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133
20. Mackenzie, I. R., Rademakers, R., and Neumann, M. (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 995-1007
21. Hanson, P. I., and Whiteheart, S. W. (2005) AAA+ proteins: have engine, will work. Nat. Rev. Mol. Cell Biol. 6, 519-529
22. DeSantis, M. E., and Shorter, J. (2012) Hsp104 drives "protein-only" positive selection of Sup35 prion strains encoding strong [PSI(+)]. Chem. Biol. 19, 1400-1410
23. Glover, J. R., and Lindquist, S. (1998) Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94, 73-82
24. Shorter, J., and Lindquist, S. (2004) Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304, 1793-1797
25. Shorter, J. (2008) Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals 16, 63-74
26. DeSantis, M. E., and Leung., E. H., Sweeny, E. A., Jackrel, M. E., Cushman-Nick, M., Neuhaus-Follini, A., Vashist, S., and Sochor., M. A., Knight, M. N, and Shorter, J. (2012) Operational plasticity enables Hsp104 to disaggregate diverse amyloid and nonamyloid clients. Cell 151, 778-793
27. Parsell, D. A., and Kowal., A. S., Singer, M. A., and Lindquist, S. (1994) Protein disaggregation mediated by heat-shock protein Hsp104. Nature 372, 475-478
28. Vashist, S., Cushman, M., and Shorter, J. (2010) Applying Hsp104 to protein-misfolding disorders. Biochem. Cell Biol. 88, 1-13
29. Sweeny, E. A., and Shorter, J. (2015) Mechanistic and structural insights into the prion-disaggregase activity of Hsp104. J. Mol. Biol. 10.1016/j.jmb.2015.11.016
30. Duennwald, M. L., Echeverria, A., and Shorter, J. (2012) Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. PLoS Biol. 10, e1001346
31. Lo Bianco, C, Shorter, J., Régulier, E., Lashuel, H., Iwatsubo, T., Lindquist, S., and Aebischer, P. (2008) Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J. Clin. Invest. 118, 3087-3097
32. Shorter, J. (2011) The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS One 6, e26319
33. Shorter, J., and Lindquist, S. (2006) Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol. Cell 23, 425-438
34. Parsell, D. A., and Kowal., A. S., and Lindquist, S. (1994) Saccharomyces cerevisiae Hsp104 protein: purification and characterization of ATP-induced structural changes. J. Biol. Chem. 269, 4480-4487
35. Sweeny, E. A., and Jackrel., M. E., Go, M. S., Sochor, M. A., and Razzo., B. M., DeSantis, M. E., Gupta, K., and Shorter, J. (2015) The Hsp104 N-terminal domain enables disaggregase plasticity and potentiation. Mol. Cell 57, 836-849
36. Wendler, P., Shorter, J., Plisson, C., Cashikar, A. G., Lindquist, S., and Saibil, H. R. (2007) Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104. Cell 131, 1366-1377
37. Carroni, M., Kummer, E., Oguchi, Y., Wendler, P., and Clare., D. K., Sinning, I., Kopp, J., Mogk, A., Bukau, B., and Saibil, H. R. (2014) Head-to-tail interactions of the coiled-coil domains regulate ClpB activity and cooperation with Hsp70 in protein disaggregation. Elife 3, e02481
38. Wendler, P., Shorter, J., Snead, D., Plisson, C., and Clare., D. K., Lindquist, S., and Saibil, H. R. (2009) Motor mechanism for protein threading through Hsp104. Mol. Cell 34, 81-92
39. Lee, S., Sielaff, B., Lee, J., and Tsai, F. T. (2010) CryoEM structure of Hsp104 and its mechanistic implication for protein disaggregation. Proc. Natl. Acad. Sci. U.S.A. 107, 8135-8140
40. Shorter, J., and Lindquist, S. (2005) Navigating the ClpB channel to solution. Nat. Struct. Mol. Biol. 12, 4-6
41. Weibezahn, J., Tessarz, P., Schlieker, C, Zahn, R., Maglica, Z., Lee, S., Zentgraf, H, Weber-Ban, E. U., Dougan, D. A., Tsai, F. T., Mogk, A., and Bukau, B. (2004) Thermotolerance requires refolding of aggregated proteins by substrate translocation through the central pore of ClpB. Cell 119, 653-665
42. Tessarz, P., Mogk, A., and Bukau, B. (2008) Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation. Mol. Microbiol. 68, 87-97
43. Lum, R., Niggemann, M., and Glover, J. R. (2008) Peptide and protein binding in the axial channel of Hsp104: insights into the mechanism of protein unfolding. J. Biol. Chem. 283, 30139-30150
44. Lum, R., and Tkach., J. M., Vierling, E., and Glover, J. R. (2004) Evidence for an unfolding/threading mechanism for protein disaggregation by Saccharomyces cerevisiae Hsp104. J. Biol. Chem. 279, 29139-29146
45. Castellano, L. M., and Bart., S. M., Holmes, V. M., Weissman, D., and Shorter, J. (2015) Repurposing Hsp104 to antagonize seminal amyloid and counter HIV infection. Chem. Biol. 22, 1074-1086
46. Li, T., and Weaver., C. L., Lin, J., Duran, E. C, Miller, J. M., and Lucius, A. L. (2015) Escherichia coli ClpB is a non-processive polypeptide translocase. Biochem. J. 470, 39-52
47. DeSantis, M. E., and Shorter, J. (2012) The elusive middle domain of Hsp104 and ClpB: location and function. Biochim. Biophys. Acta 1823, 29-39
48. Franzmann, T. M., Czekalla, A., and Walter, S. G. (2011) Regulatory circuits of the AAA+disaggregase Hsp104. J. Biol. Chem. 286, 17992-18001
49. Schirmer, E. C, Queitsch, C, and Kowal., A. S., Parsell, D. A., and Lindquist, S. (1998) The ATPase activity of Hsp104, effects of environmental conditions and mutations. J. Biol. Chem. 273, 15546-15552
50. Grimminger-Marquardt, V., and Lashuel, H. A. (2010) Structure and function of the molecular chaperone Hsp104 from yeast. Biopolymers 93, 252-276
51. Schirmer, E. C, Ware, D. M., Queitsch, C, and Kowal., A. S., and Lindquist, S. L. (2001) Subunit interactions influence the biochemical and biological properties of Hsp104. Proc. Natl. Acad. Sci. U.S.A. 98, 914-919
52. Hattendorf, D. A., and Lindquist, S. L. (2002) Cooperative kinetics of both Hsp104 ATPase domains and interdomain communication revealed by AAA sensor-1 mutants. EMBO J. 21, 12-21
53. Narayanan, S., Walter, S., and Reif, B. (2006) Yeast prion-protein, sup35, fibril formation proceeds by addition and substraction of oligomers. Chembiochem 7, 757-765
54. Liu, Y. H., and Han., Y. L., Song, J., Wang, Y., Jing, Y. Y., Shi, Q., Tian, C, and Wang., Z. Y., Li, C. P., Han, J., and Dong, X. P. (2011) Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro. Int. J. Biochem. Cell Biol. 43, 768-774
55. Shorter, J., and Lindquist, S. (2008) Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J. 27, 2712-2724
56. Sweeny, E. A., and Shorter, J. (2008) Prion proteostasis: Hsp104 meets its supporting cast. Prion 2, 135-140
57. Torrente, M. P., and Shorter, J. (2013) The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins. Prion 7, 457-463
58. Cashikar, A. G., Duennwald, M., and Lindquist, S. L. (2005) A chaperone pathway in protein disaggregation: Hsp26 alters the nature of protein aggregates to facilitate reactivation by Hsp104. J. Biol. Chem. 280, 23869-23875
59. Haslbeck, M., Miess, A., Stromer, T., Walter, S., and Buchner, J. (2005) Disassembling protein aggregates in the yeast cytosol: the cooperation of Hsp26 with Ssa1 and Hsp104. J. Biol. Chem. 280, 23861-23868
60. Doyle, S. M., Shorter, J., Zolkiewski, M., Hoskins, J. R., Lindquist, S., and Wickner, S. (2007) Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity. Nat. Struct. Mol. Biol. 14, 114-122
61. DeSantis, M. E., and Sweeny., E. A., Snead, D., Leung, E. H., and Go., M. S., Gupta, K., Wendler, P., and Shorter, J. (2014) Conserved distal loop residues in the Hsp104 and ClpB middle domain contact nucleotide-binding domain 2 and enable Hsp70-dependent protein disaggregation. J. Biol. Chem. 289, 848-867
62. Jackrel, M. E., and DeSantis., M. E., Martinez, B. A., Castellano, L. M., and Stewart., R. M., Caldwell, K. A., Caldwell, G. A., and Shorter, J. (2014) Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156, 170-182
63. Jackrel, M. E., and Shorter, J. (2014) Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Dis. Model. Mech. 7, 1175-1184
64. Jackrel, M. E., Tariq, A., Yee, K., Weitzman, R., and Shorter, J. (2014) Isolating potentiated Hsp104 variants using yeast proteinopathy models. J. Vis. Exp. 93, e52089
65. Jackrel, M. E., and Shorter, J. (2014) Reversing deleterious protein aggregation with re-engineered protein disaggregases. Cell Cycle 13, 1379-1383
66. Jackrel, M. E., and Shorter, J. (2015) Engineering enhanced protein disaggregases for neurodegenerative disease. Prion 9, 90-109
67. Jackrel, M. E., Yee, K., Tariq, A., Chen, A. I., and Shorter, J. (2015) Disparate mutations confer therapeutic gain of Hsp104 function. ACS Chem. Biol. 10, 2672-2679
68. Torrente, M. P., and Castellano., L. M., and Shorter, J. (2014) Suramin inhibits Hsp104ATPase and disaggregase activity. PLoS One 9, e110115
69. Sweeny, E. A., and DeSantis., M. E., and Shorter, J. (2011) Purification of hsp104, a protein disaggregase. J. Vis. Exp. 10.3791/3190
70. Werbeck, N. D., Schlee, S., and Reinstein, J. (2008) Coupling and dynamics of subunits in the hexameric AAA+ chaperone ClpB. J. Mol. Biol. 378, 178-190
71. Moreau, M. J., and McGeoch., A. T., Lowe, A. R., Itzhaki, L. S., and Bell, S. D. (2007) ATPase site architecture and helicase mechanism of an archaeal MCM. Mol. Cell 28, 304-314
72. Sanchez, Y., and Lindquist, S. L. (1990) HSP104 required for induced thermotolerance. Science 248, 1112-1115
73. Johnson, B. S., and McCaffery., J. M., Lindquist, S., and Gitler, A. D. (2008) A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U.S.A. 105, 6439-6444
74. Johnson, B. S., Snead, D., Lee, J. J., and McCaffery., J. M., Shorter, J., and Gitler, A. D. (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329-20339
75. Sun, Z., Diaz, Z., Fang, X., Hart, M. P., Chesi, A., Shorter, J., and Gitler, A. D. (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 9, e1000614
76. Gietz, R. D., and Schiestl, R. H. (2007) High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc. 2, 31-34
77. Schirmer, E. C, Homann, O. R., and Kowal., A. S., and Lindquist, S. (2004) Dominant gain-of-function mutations in Hsp104p reveal crucial roles for the middle region. Mol. Biol. Cell 15, 2061-2072
78. Cashikar, A. G., Schirmer, E. C, Hattendorf, D. A., and Glover., J. R., Ramakrishnan, M. S., Ware, D. M., and Lindquist, S. L. (2002) Defining a pathway of communication from the C-terminal peptide binding domain to the N-terminal ATPase domain in a AAA protein. Mol. Cell 9, 751-760
79. Outeiro, T. F., and Lindquist, S. (2003) Yeast cells provide insight into α-synuclein biology and pathobiology. Science 302, 1772-1775
80. Cushman, M., and Johnson., B. S., King, O. D., Gitler, A. D., and Shorter, J. (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J. Cell Sci. 123, 1191-1201
81. Ju, S., and Tardiff., D. F., Han, H, Divya, K., Zhong, Q., Maquat, L. E., and Bosco., D. A., Hayward, L. J., Brown, R. H., Jr., Lindquist, S., Ringe, D., and Petsko, G. A. (2011) A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol. 9, e1001052
82. Schaupp, A., Marcinowski, M., Grimminger, V., Bösl, B., and Walter, S. (2007) Processing of proteins by the molecular chaperone Hsp104. J. Mol. Biol. 370, 674-686
83. Yu, A., Shibata, Y., Shah, B., Calamini, B., Lo, D. C, and Morimoto, R. I. (2014) Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition. Proc. Natl. Acad. Sci. U.S.A. 111, E1481-E1490
84. Auluck, P. K., and Chan., H. Y., Trojanowski, J. Q., Lee, V. M., and Bonini, N.M. (2002) Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865-868
85. Takahashi, A., Hara, H., Kurahashi, H, and Nakamura, Y. (2007) A systematic evaluation of the function of the protein-remodeling factor Hsp104 in [PSI+] prion propagation in S. cerevisiae by comprehensive chromosomal mutations. Prion 1, 69-77